A Phase 3 interventional study of Tranexamic acid and 0.9% saline in Sepsis, sponsored by Assiut University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2025-08-05.
Sponsored by Assiut University · Phase 3, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 33 studies in Sepsis by Assiut University — 23 open to participants now, 23 under way, 1 of them phase 3. Sepsis · Assiut University.
Among the 33 studies in Sepsis by Assiut University, this one is one of 3 that started in 2021, is the only one in phase 3, reaches primary completion later than 8 of the 22 other live ones, and was the 6th registered.
2,422 studies on the registry are indexed under Sepsis; 543 are open to participants now.
Browse Sepsis studies →23 of the 33 studies in Sepsis by Assiut University are open now, in 1 country. Recruiting first, the newest first:
Assiut University
Ages 18–65
Assiut University
Ages 18+
Assiut University
Ages 18+
Assiut University
Ages 18+
Assiut University
Ages 18+
By country, each count listing its studies:
Of the 319 Sepsis studies recruiting now, 212 (66%) set no upper age limit and 52 (16%) stop at 75 or younger; 67 take children under 18; 43 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
33 studies; the count open now beside each. This study's row is marked.
First in 2016; this study’s year is marked. 3 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 80 is below the median of 102 across 1,169 interventional studies indexed under Sepsis.
Median enrollment 85 across the 4 interventional studies, 100 across the 29 observational. Of the 1 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Assiut University is the lead sponsor of 5,094 studies on the registry; 2,187 are open to participants now.
Of its 14 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.
11 of the studies in Sepsis by Assiut University that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04910464Phase 3Assiut UniversityEarly Tranexamic Acid and Modulating the Inflammatory Response in Sepsis | 2027-01-10 |
| NCT07832903Assiut UniversitySerial Platelet Count and Indices for Predicting In-Hospital Mortality in Sepsis | 2026-11 |
| NCT07030114Assiut UniversityThe Study Seeks to Determine Potential Correlations Between Ventilation and Hematological Alterations, Contributing to a Better Understanding of Its Physiological Effects and Optimizing Patient Management in Critical Care Settings. | 2027-04 |
| NCT07663084Assiut UniversityCBC Indices and Serum Lactate in Neonatal Sepsis | 2027-08 |
| NCT07739251Assiut UniversityRelation of Serum Phosphate Level to the Duration of Mechanical Ventilation in Patient With Sepsis | 2027-09 |
Add all 11 to your calendar (.ics) → With an account.
Among the 33 studies in Sepsis by Assiut University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
In this study, our aim is to investigate the role tranexamic acid in modulating inflammation in patients with sepsis.
A written informed consent will be taken from the patients or their relatives.Patients will be assigned randomly to two groups (40 subjects each) with qSOFA ≥2.
In (Group T) administer 1 gram of tranexamic acid (TXA) in 100 ml of 0.9% normal saline, intravenous over 10 minutes as soon as possible but no later than three hours after diagnosis, infuse a second gram of tranexamic acid (TXA) IV over 8 hours in 0.9% normal saline for the first 3 days. In (Group C) administer the same volume (100 ml normal saline)and same duration (first three days)for controlled patients.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Give 1 gram of TXA in 100 ml of 0.9% normal saline, intravenous over 10 minutes as soon as possible but no later than three hours after diagnosis, infuse a second gram of TXA IV over 8 hours in 0.9% normal saline for the first 3 days.
Drug: Tranexamic acid
Give the same volume (100 ml normal saline) and same duration (first three days).
Other: 0.9% saline
administer 1 gram of TXA in 100 ml of 0.9% normal saline, intravenous over 10 minutes as soon as possible but no later than three hours after diagnosis, infuse a second gram of TXA IV over 8 hours in 0.9% normal saline for first 3 days.
Also known as: Cyclokapron
administer the same volume (100ml normal saline) and same duration (first three days).
Also known as: Normal saline
ICU mortality
Short-term ICU mortality within 7days of admission and intervention
Time frame: 7days
Neutrophil/lymphocyte ratio (NLR)
From complete blood count, divide absolute number of neutrophils on lymphocyte to assess and follow up the inflammatory response in sepsis
Time frame: 4 days
Interleukin-6 (IL-6) serum level
Measurement of interleukin-6 (IL-6) serum level to assess and follow up the inflammatory response in sepsis
Time frame: 4 days
Glasgow coma scale (GCS)
Assessing the conscious level of patients by Glasgow Coma Scale (3\_15)after ICU admission and intervention start give an idea on brain dysfunction in sepsis where high scores are associated with low mortality and low scores are associated with high mortality
Time frame: 5 days
ICU stay
Days of patients admission in ICU
Time frame: 7 days
Length of hospitalization
Days of patients admission in hospital
Time frame: 7 days
Plan to share: Undecided
No publications or documents are linked to this record.
Started Jun 2021 (actual). Primary completion is estimated for Jan 2027, 67 months after the start.
Of 58 non-industry phase 3 interventional studies under Sepsis, half reached primary completion within 39 months of starting (the median), counting those still running; a quarter within 24 and three quarters within 63. This study's planned 67 months is above that.
Counting every sponsor, half of 66 studies reached it within 39 months; a quarter within 24 and three quarters within 65.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Tranexamic Acid